Table of Contents Executive Summary 1 Industry Overview of Leiomyosarcoma Drug 1.1 Definition of Leiomyosarcoma Drug 1.2 Leiomyosarcoma Drug Segment by Type 1.2.1 Global Leiomyosarcoma Drug Production Growth Rate Comparison by Types (2014-2025) 1.2.2 AL-3818 1.2.3 BGB-290 1.2.4 C-21 1.2.5 Others 1.3 Leiomyosarcoma Drug Segment by Applications 1.3.1 Global Leiomyosarcoma Drug Consumption Comparison by Applications (2014-2025) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Global Leiomyosarcoma Drug Overall Market 1.4.1 Global Leiomyosarcoma Drug Revenue (2014-2025) 1.4.2 Global Leiomyosarcoma Drug Production (2014-2025) 1.4.3 North America Leiomyosarcoma Drug Status and Prospect (2014-2025) 1.4.4 Europe Leiomyosarcoma Drug Status and Prospect (2014-2025) 1.4.5 China Leiomyosarcoma Drug Status and Prospect (2014-2025) 1.4.6 Japan Leiomyosarcoma Drug Status and Prospect (2014-2025) 1.4.7 Southeast Asia Leiomyosarcoma Drug Status and Prospect (2014-2025) 1.4.8 India Leiomyosarcoma Drug Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Leiomyosarcoma Drug 2.3 Manufacturing Process Analysis of Leiomyosarcoma Drug 2.4 Industry Chain Structure of Leiomyosarcoma Drug 3 Development and Manufacturing Plants Analysis of Leiomyosarcoma Drug 3.1 Capacity and Commercial Production Date 3.2 Global Leiomyosarcoma Drug Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Leiomyosarcoma Drug 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Leiomyosarcoma Drug Production and Capacity Analysis 4.2 Leiomyosarcoma Drug Revenue Analysis 4.3 Leiomyosarcoma Drug Price Analysis 4.4 Market Concentration Degree 5 Leiomyosarcoma Drug Regional Market Analysis 5.1 Leiomyosarcoma Drug Production by Regions 5.1.1 Global Leiomyosarcoma Drug Production by Regions 5.1.2 Global Leiomyosarcoma Drug Revenue by Regions 5.2 Leiomyosarcoma Drug Consumption by Regions 5.3 North America Leiomyosarcoma Drug Market Analysis 5.3.1 North America Leiomyosarcoma Drug Production 5.3.2 North America Leiomyosarcoma Drug Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Leiomyosarcoma Drug Import and Export 5.4 Europe Leiomyosarcoma Drug Market Analysis 5.4.1 Europe Leiomyosarcoma Drug Production 5.4.2 Europe Leiomyosarcoma Drug Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Leiomyosarcoma Drug Import and Export 5.5 China Leiomyosarcoma Drug Market Analysis 5.5.1 China Leiomyosarcoma Drug Production 5.5.2 China Leiomyosarcoma Drug Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Leiomyosarcoma Drug Import and Export 5.6 Japan Leiomyosarcoma Drug Market Analysis 5.6.1 Japan Leiomyosarcoma Drug Production 5.6.2 Japan Leiomyosarcoma Drug Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Leiomyosarcoma Drug Import and Export 5.7 Southeast Asia Leiomyosarcoma Drug Market Analysis 5.7.1 Southeast Asia Leiomyosarcoma Drug Production 5.7.2 Southeast Asia Leiomyosarcoma Drug Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Leiomyosarcoma Drug Import and Export 5.8 India Leiomyosarcoma Drug Market Analysis 5.8.1 India Leiomyosarcoma Drug Production 5.8.2 India Leiomyosarcoma Drug Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Leiomyosarcoma Drug Import and Export 6 Leiomyosarcoma Drug Segment Market Analysis (by Type) 6.1 Global Leiomyosarcoma Drug Production by Type 6.2 Global Leiomyosarcoma Drug Revenue by Type 6.3 Leiomyosarcoma Drug Price by Type 7 Leiomyosarcoma Drug Segment Market Analysis (by Application) 7.1 Global Leiomyosarcoma Drug Consumption by Application 7.2 Global Leiomyosarcoma Drug Consumption Market Share by Application (2014-2019) 8 Leiomyosarcoma Drug Major Manufacturers Analysis 8.1 Advenchen Laboratories, LLC 8.1.1 Advenchen Laboratories, LLC Leiomyosarcoma Drug Production Sites and Area Served 8.1.2 Advenchen Laboratories, LLC Product Introduction, Application and Specification 8.1.3 Advenchen Laboratories, LLC Leiomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 BeiGene, Ltd. 8.2.1 BeiGene, Ltd. Leiomyosarcoma Drug Production Sites and Area Served 8.2.2 BeiGene, Ltd. Product Introduction, Application and Specification 8.2.3 BeiGene, Ltd. Leiomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Cell Medica Limited 8.3.1 Cell Medica Limited Leiomyosarcoma Drug Production Sites and Area Served 8.3.2 Cell Medica Limited Product Introduction, Application and Specification 8.3.3 Cell Medica Limited Leiomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Karyopharm Therapeutics, Inc. 8.4.1 Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Production Sites and Area Served 8.4.2 Karyopharm Therapeutics, Inc. Product Introduction, Application and Specification 8.4.3 Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Merck & Co., Inc. 8.5.1 Merck & Co., Inc. Leiomyosarcoma Drug Production Sites and Area Served 8.5.2 Merck & Co., Inc. Product Introduction, Application and Specification 8.5.3 Merck & Co., Inc. Leiomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Mirati Therapeutics Inc. 8.6.1 Mirati Therapeutics Inc. Leiomyosarcoma Drug Production Sites and Area Served 8.6.2 Mirati Therapeutics Inc. Product Introduction, Application and Specification 8.6.3 Mirati Therapeutics Inc. Leiomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Novartis AG 8.7.1 Novartis AG Leiomyosarcoma Drug Production Sites and Area Served 8.7.2 Novartis AG Product Introduction, Application and Specification 8.7.3 Novartis AG Leiomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Vicore Pharma AB 8.8.1 Vicore Pharma AB Leiomyosarcoma Drug Production Sites and Area Served 8.8.2 Vicore Pharma AB Product Introduction, Application and Specification 8.8.3 Vicore Pharma AB Leiomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 9 Development Trend of Analysis of Leiomyosarcoma Drug Market 9.1 Global Leiomyosarcoma Drug Market Trend Analysis 9.1.1 Global Leiomyosarcoma Drug Market Size (Volume and Value) Forecast 2019-2025 9.2 Leiomyosarcoma Drug Regional Market Trend 9.2.1 North America Leiomyosarcoma Drug Forecast 2019-2025 9.2.2 Europe Leiomyosarcoma Drug Forecast 2019-2025 9.2.3 China Leiomyosarcoma Drug Forecast 2019-2025 9.2.4 Japan Leiomyosarcoma Drug Forecast 2019-2025 9.2.5 Southeast Asia Leiomyosarcoma Drug Forecast 2019-2025 9.2.6 India Leiomyosarcoma Drug Forecast 2019-2025 9.3 Leiomyosarcoma Drug Market Trend (Product Type) 9.4 Leiomyosarcoma Drug Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Leiomyosarcoma Drug Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Leiomyosarcoma Drug Table Global Leiomyosarcoma Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global Leiomyosarcoma Drug Production Market Share by Types in 2018 Figure AL-3818 Product Picture Figure BGB-290 Product Picture Figure C-21 Product Picture Figure Others Product Picture Table Global Leiomyosarcoma Drug Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global Leiomyosarcoma Drug Consumption Market Share by Applications in 2018 Figure Clinic Figure Hospital Figure Others Figure Global Leiomyosarcoma Drug Revenue (Million USD) (2014-2025) Figure Global Leiomyosarcoma Drug Production (K Pcs) (2014-2025) Figure North America Leiomyosarcoma Drug Market Size (Million USD) (2014-2025) Figure Europe Leiomyosarcoma Drug Market Size (Million USD) (2014-2025) Figure China Leiomyosarcoma Drug Market Size (Million USD) (2014-2025) Figure Japan Leiomyosarcoma Drug Market Size (Million USD) (2014-2025) Figure Southeast Asia Leiomyosarcoma Drug Market Size (Million USD) (2014-2025) Figure India Leiomyosarcoma Drug Market Size (Million USD) (2014-2025) Table Leiomyosarcoma Drug Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Leiomyosarcoma Drug in 2018 Figure Manufacturing Process Analysis of Leiomyosarcoma Drug Figure Industry Chain Structure of Leiomyosarcoma Drug Table Capacity and Commercial Production Date of Key Manufacturers Table Global Leiomyosarcoma Drug Manufacturing Plants Distribution Table Leiomyosarcoma Drug Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Leiomyosarcoma Drug Capacity (K Pcs) of Major Manufacturers (2014-2019) Table Leiomyosarcoma Drug Production (K Pcs) of Major Manufacturers (2014-2019) Table Leiomyosarcoma Drug Production Market Share of Major Manufacturers (2014-2019) Figure Leiomyosarcoma Drug Production Share by Manufacturers in 2018 Table Leiomyosarcoma Drug Revenue (Million US$) of Major Manufacturers (2014-2019) Table Leiomyosarcoma Drug Revenue Market Share of Major Manufacturers (2014-2019) Figure Leiomyosarcoma Drug Revenue Share by Manufacturers in 2018 Table Leiomyosarcoma Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Leiomyosarcoma Drug Production by Regions 2014-2019 (K Pcs) Table Global Leiomyosarcoma Drug Production Market Share by Regions 2014-2019 Figure Global Leiomyosarcoma Drug Production Market Share by Regions in 2018 Table Global Leiomyosarcoma Drug Revenue by Regions 2014-2019 (Million USD) Table Global Leiomyosarcoma Drug Revenue Market Share by Regions 2014-2019 Figure Global Leiomyosarcoma Drug Revenue Market Share by Regions in 2018 Table Global Leiomyosarcoma Drug Consumption by Regions 2014-2019 (K Pcs) Table Global Leiomyosarcoma Drug Consumption Market Share by Regions 2014-2019 Figure North America Leiomyosarcoma Drug Production Growth Rate 2014-2019 (K Pcs) Figure North America Leiomyosarcoma Drug Revenue Growth Rate 2014-2019 (Million USD) Table North America Leiomyosarcoma Drug Production, Consumption Import and Export (K Pcs) Figure Europe Leiomyosarcoma Drug Production Growth Rate 2014-2019 (K Pcs) Figure Europe Leiomyosarcoma Drug Revenue Growth Rate 2014-2019 (Million USD) Table Europe Leiomyosarcoma Drug Production, Consumption Import and Export (K Pcs) Figure China Leiomyosarcoma Drug Production Growth Rate 2014-2019 (K Pcs) Figure China Leiomyosarcoma Drug Revenue Growth Rate 2014-2019 (Million USD) Table China Leiomyosarcoma Drug Production, Consumption Import and Export (K Pcs) Figure Japan Leiomyosarcoma Drug Production Growth Rate 2014-2019 (K Pcs) Figure Japan Leiomyosarcoma Drug Revenue Growth Rate 2014-2019 (Million USD) Table Japan Leiomyosarcoma Drug Production, Consumption Import and Export (K Pcs) Figure Southeast Asia Leiomyosarcoma Drug Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia Leiomyosarcoma Drug Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Leiomyosarcoma Drug Production, Consumption Import and Export (K Pcs) Figure India Leiomyosarcoma Drug Production Growth Rate 2014-2019 (K Pcs) Figure India Leiomyosarcoma Drug Revenue Growth Rate 2014-2019 (Million USD) Table India Leiomyosarcoma Drug Production, Consumption Import and Export (K Pcs) Figure Global Consumption Leiomyosarcoma Drug Market Share by Application (2014-2019) Figure Global Value (Consumption) Leiomyosarcoma Drug Market Share by Application (2014-2019) Table Advenchen Laboratories, LLC Leiomyosarcoma Drug Production Sites and Area Served Table Advenchen Laboratories, LLC Leiomyosarcoma Drug Product Introduction, Application and Specification Table Advenchen Laboratories, LLC Leiomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Advenchen Laboratories, LLC Leiomyosarcoma Drug Production Growth Rate (2014-2019) Table Advenchen Laboratories, LLC Leiomyosarcoma Drug Production Market Share (2014-2019) Figure Advenchen Laboratories, LLC Leiomyosarcoma Drug Revenue Market Share (2014-2019) Table Advenchen Laboratories, LLC Leiomyosarcoma Drug Main Business and Markets Served Table BeiGene, Ltd. Leiomyosarcoma Drug Production Sites and Area Served Table BeiGene, Ltd. Leiomyosarcoma Drug Product Introduction, Application and Specification Table BeiGene, Ltd. Leiomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table BeiGene, Ltd. Leiomyosarcoma Drug Production Growth Rate (2014-2019) Table BeiGene, Ltd. Leiomyosarcoma Drug Production Market Share (2014-2019) Figure BeiGene, Ltd. Leiomyosarcoma Drug Revenue Market Share (2014-2019) Table BeiGene, Ltd. Leiomyosarcoma Drug Main Business and Markets Served Table Cell Medica Limited Leiomyosarcoma Drug Production Sites and Area Served Table Cell Medica Limited Leiomyosarcoma Drug Product Introduction, Application and Specification Table Cell Medica Limited Leiomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Cell Medica Limited Leiomyosarcoma Drug Production Growth Rate (2014-2019) Table Cell Medica Limited Leiomyosarcoma Drug Production Market Share (2014-2019) Figure Cell Medica Limited Leiomyosarcoma Drug Revenue Market Share (2014-2019) Table Cell Medica Limited Leiomyosarcoma Drug Main Business and Markets Served Table Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Production Sites and Area Served Table Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Product Introduction, Application and Specification Table Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Production Growth Rate (2014-2019) Table Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Production Market Share (2014-2019) Figure Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Revenue Market Share (2014-2019) Table Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Main Business and Markets Served Table Merck & Co., Inc. Leiomyosarcoma Drug Production Sites and Area Served Table Merck & Co., Inc. Leiomyosarcoma Drug Product Introduction, Application and Specification Table Merck & Co., Inc. Leiomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Merck & Co., Inc. Leiomyosarcoma Drug Production Growth Rate (2014-2019) Table Merck & Co., Inc. Leiomyosarcoma Drug Production Market Share (2014-2019) Figure Merck & Co., Inc. Leiomyosarcoma Drug Revenue Market Share (2014-2019) Table Merck & Co., Inc. Leiomyosarcoma Drug Main Business and Markets Served Table Mirati Therapeutics Inc. Leiomyosarcoma Drug Production Sites and Area Served Table Mirati Therapeutics Inc. Leiomyosarcoma Drug Product Introduction, Application and Specification Table Mirati Therapeutics Inc. Leiomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Mirati Therapeutics Inc. Leiomyosarcoma Drug Production Growth Rate (2014-2019) Table Mirati Therapeutics Inc. Leiomyosarcoma Drug Production Market Share (2014-2019) Figure Mirati Therapeutics Inc. Leiomyosarcoma Drug Revenue Market Share (2014-2019) Table Mirati Therapeutics Inc. Leiomyosarcoma Drug Main Business and Markets Served Table Novartis AG Leiomyosarcoma Drug Production Sites and Area Served Table Novartis AG Leiomyosarcoma Drug Product Introduction, Application and Specification Table Novartis AG Leiomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Novartis AG Leiomyosarcoma Drug Production Growth Rate (2014-2019) Table Novartis AG Leiomyosarcoma Drug Production Market Share (2014-2019) Figure Novartis AG Leiomyosarcoma Drug Revenue Market Share (2014-2019) Table Novartis AG Leiomyosarcoma Drug Main Business and Markets Served Table Vicore Pharma AB Leiomyosarcoma Drug Production Sites and Area Served Table Vicore Pharma AB Leiomyosarcoma Drug Product Introduction, Application and Specification Table Vicore Pharma AB Leiomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Vicore Pharma AB Leiomyosarcoma Drug Production Growth Rate (2014-2019) Table Vicore Pharma AB Leiomyosarcoma Drug Production Market Share (2014-2019) Figure Vicore Pharma AB Leiomyosarcoma Drug Revenue Market Share (2014-2019) Table Vicore Pharma AB Leiomyosarcoma Drug Main Business and Markets Served Figure Global Leiomyosarcoma Drug Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global Leiomyosarcoma Drug Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Leiomyosarcoma Drug Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America Leiomyosarcoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America Leiomyosarcoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Leiomyosarcoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe Leiomyosarcoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Leiomyosarcoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China Leiomyosarcoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Leiomyosarcoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan Leiomyosarcoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Leiomyosarcoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia Leiomyosarcoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Leiomyosarcoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India Leiomyosarcoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of Leiomyosarcoma Drug by Type (2019-2025) Table Global Consumption (K Pcs) of Leiomyosarcoma Drug by Application (2019-2025) Table Leiomyosarcoma Drug Distributors List Table Leiomyosarcoma Drug Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Advenchen Laboratories, LLC BeiGene, Ltd. Cell Medica Limited Karyopharm Therapeutics, Inc. Merck & Co., Inc. Mirati Therapeutics Inc. Novartis AG Vicore Pharma AB